Press releases
Regulatory press release 2025-08-26
First day of trading in subscription rights and BTAs moved to August 27
Regulatory press release 2025-08-25
Xspray publishes disclosure document regarding rights issue
Regulatory press release 2025-08-25
Xspray receives additional subscription undertakings of SEK 20 million in the ongoing rights issue
Press release 2025-08-19
Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform
Regulatory press release 2025-08-15
Interim Report Second Quarter 2025
-
Latest report
Interim Report Q2 2025 -
Subscribe
Get our latest press releases and reports